tickrz reports
  
tickrz rank
B
Baxter International Inc (BAX)
Healthcare | Medical Instruments & Supplies
CEO: Joe Almeida
Employees: 50000
baxter.com
FACTOR RANKINGSFACTOR SCREENER 
Pure Value Rank215Dividend Rank5
Moat Rank164Financial Strength Rank14
Growth Rank252Momentum Rank101
DIVIDEND ANALYSIS
Dividend Yield0.89%
Payout Ratio14.81%
3 yr Dividend Growth-35.93%
VALUATION RATIOS
P/E Ratio17.4x
P/B Ratio3.72x
P/S Ratio3.15x
EV/EBITDA Ratio11.47x
FINANCIAL STRENGTH
Piotroski F-Score8
Debt-to-Equity32%
Interest Coverage38.56x
MOAT
ROE20.99%
ROIC9.6%
Net Margin48.86%
GROWTH
5 yr EPS Growth18.26%
5 yr SPS Growth-6.06%
5 yr BPS Growth5.53%
Baxter International Inc's strong Dividend Rank may warrant a closer look for investors seeking dividend paying stocks
 tickrz summary
Baxter International Inc receives a B ranking in our proprietary ranking system that combines valuation, moat, operational performance, and financial strength. View the Top 50 tickrz ranked stocks here.
 value
 pure value ranking Warren Buffett ranking
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. Baxter International Inc's valuation score is comprised of a P/E ratio of 17.4x, a P/B ratio of 3.7x, a P/S ratio of 3.2x, and an EV/EBITDA ratio of 11.5x. Baxter International Inc ranks 215 out of the S&P 500 constituents on valuation--a relatively average score.Baxter International Inc ranks 73 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a strong score, meaning it ranks highly on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, Baxter International Inc warrants further investigation.

 quality
 moat financial strength
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is average. Our analysis of its moat reveals neither a durable moat or enduring competitive advantages.Baxter International Inc has a Piotroski F Score of 8 out of 9. The F Score examines changes in profitability, leverage, liquidity, and operating efficiency. Interest coverage of 38.56x, a debt/equity ratio of 32% and a Moat Rank of 164 translate to a strong Financial Strength score.


 momentum
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors. The company has seen its stock appreciate by 28% over the last 12 months. This performance is strong compared to other stocks in the S&P 500, earning it a rank of 101. Baxter International Inc's strong 12 month stock performance will appeal to momentum investors.

 yield
 value + yield
Shares currently yield 0.89%. Our dividend ranking approach looks at a company's dividend growth rate, payout ratio, business moat, and valuation. Based on our methodology, Baxter International Inc ranks 5 among the S&P 500 constituents. Investors looking for undervalued dividend stocks will want to closely investigate Baxter International Inc.

 growth
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value produce an average score. 18.3% 5 year annualized EPS growth, -6.1% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 5.5% combine to produce this average score.

Baxter International Inc (BAX)
Healthcare | Medical Instruments & Supplies
CEO: Joe Almeida
Employees: 50000
baxter.com


tickrz rank
B

VALUATION RATIOS
P/E Ratio17.4x
P/B Ratio3.72x
P/S Ratio3.15x
EV/EBITDA Ratio11.47x
DIVIDEND ANALYSIS
Dividend Yield0.89%
Payout Ratio14.81%
3 yr Dividend Growth-35.93%
FINANCIAL STRENGTH
Piotroski F-Score8
Debt-to-Equity32%
Interest Coverage38.56x
MOAT
ROE20.99%
ROIC9.6%
Net Margin48.86%
GROWTH
5 yr EPS Growth18.26%
5 yr SPS Growth-6.06%
5 yr BPS Growth5.53%

TICKRZ RANK
Baxter International Inc receives a B ranking in our proprietary ranking system that combines valuation, moat, operational performance, and financial strength. View the Top 50 tickrz ranked stocks here.

PURE VALUE
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. Baxter International Inc's valuation score is comprised of a P/E ratio of 17.4x, a P/B ratio of 3.7x, a P/S ratio of 3.2x, and an EV/EBITDA ratio of 11.5x. Baxter International Inc ranks 215 out of the S&P 500 constituents on valuation--a relatively average score.

WARREN BUFFETT RANKING
Baxter International Inc ranks 73 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a strong score, meaning it ranks highly on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, Baxter International Inc warrants further investigation.

MOAT
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is average. Our analysis of its moat reveals neither a durable moat or enduring competitive advantages.

FINANCIAL STRENGTH
Baxter International Inc has a Piotroski F Score of 8 out of 9. The F Score examines changes in profitability, leverage, liquidity, and operating efficiency. Interest coverage of 38.56x, a debt/equity ratio of 32% and a Moat Rank of 164 translate to a strong Financial Strength score.

MOMENTUM
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors. The company has seen its stock appreciate by 28% over the last 12 months. This performance is strong compared to other stocks in the S&P 500, earning it a rank of 101. Baxter International Inc's strong 12 month stock performance will appeal to momentum investors.

VALUE + YIELD
Shares currently yield 0.89%. Our dividend ranking approach looks at a company's dividend growth rate, payout ratio, business moat, and valuation. Based on our methodology, Baxter International Inc ranks 5 among the S&P 500 constituents. Investors looking for undervalued dividend stocks will want to closely investigate Baxter International Inc.

GROWTH
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value produce an average score. 18.3% 5 year annualized EPS growth, -6.1% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 5.5% combine to produce this average score.